56.4% Return Seen to Date on SmarTrend Halozyme Therapeutics Call (HALO)

SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on April 16th, 2015 at $15.57. In approximately 3 months, Halozyme Therapeutics has returned 56.38% as of today's recent price of...